Cargando…
Identification and Pharmacological Inactivation of the MYCN Gene Network as a Therapeutic Strategy for Neuroblastic Tumor Cells
The MYC family of transcription factors consists of three well characterized members, c-MYC, L-MYC, and MYCN, deregulated in the majority of human cancers. In neuronal tumors such as neuroblastoma, MYCN is frequently activated by gene amplification, and reducing its expression by RNA interference ha...
Autores principales: | Chayka, Olesya, D'Acunto, Cosimo Walter, Middleton, Odette, Arab, Maryam, Sala, Arturo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303671/ https://www.ncbi.nlm.nih.gov/pubmed/25477524 http://dx.doi.org/10.1074/jbc.M114.624056 |
Ejemplares similares
-
Physical Interaction between MYCN Oncogene and Polycomb Repressive Complex 2 (PRC2) in Neuroblastoma: FUNCTIONAL AND THERAPEUTIC IMPLICATIONS
por: Corvetta, Daisy, et al.
Publicado: (2013) -
A chemical screen identifies the chemotherapeutic drug topotecan as a specific inhibitor of the B-MYB/MYCN axis in neuroblastoma
por: Sottile, Francesco, et al.
Publicado: (2012) -
Addiction of MYCN Amplified Tumours to B-MYB Underscores a Reciprocal Regulatory Loop
por: Gualdrini, Francesco, et al.
Publicado: (2010) -
Genomotyping of Pseudomonas putida strains using P. putida KT2440-based high-density DNA microarrays: implications for transcriptomics studies
por: Ballerstedt, Hendrik, et al.
Publicado: (2007) -
Functional Gene Expression Profiling in Yeast Implicates Translational Dysfunction in Mutant Huntingtin Toxicity
por: Tauber, Eran, et al.
Publicado: (2011)